Radiation dosimetry of whole-body dual-tracer 18F-FDG and 11C-acetate PET/CT for hepatocellular carcinoma

D Liu, PL Khong, Y Gao, U Mahmood… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Combined whole-body dual-tracer (18F-FDG and 11C-acetate) PET/CT is increasingly used
for staging hepatocellular carcinoma, with only limited studies investigating the radiation …

Test–retest reproducibility of 18F-FDG PET/CT uptake in cancer patients within a qualified and calibrated local network

BF Kurland, LM Peterson, AT Shields… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Calibration and reproducibility of quantitative 18F-FDG PET measures are essential for
adopting integral 18F-FDG PET/CT biomarkers and response measures in multicenter …

Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma

C Ho, S Chen, DWC Yeung… - Journal of Nuclear …, 2007 - Soc Nuclear Med
We have reported previously that 11C-acetate (11C-ACT) PET was complementary to 18F-
FDG PET in the evaluation of primary hepatocellular carcinoma (HCC) in relation to the …

A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma

JW Park, JH Kim, SK Kim, KW Kang… - Journal of Nuclear …, 2008 - Soc Nuclear Med
Because 18F-FDG PET has insufficient sensitivity for the detection of hepatocellular
carcinoma (HCC), 11C-acetate PET has been proposed as another technique for this use …

Head-to-head intra-individual comparison of total-body 2-[18F]FDG PET/CT and digital PET/CT in patients with malignant tumor: how sensitive could it be?

X Chen, P Hu, H Yu, H Tan, Y He, S Cao, Y Zhou… - European …, 2023 - Springer
Objectives To comparatively evaluate the lesion-detecting ability of 2-[18F] FDG total-body
PET/CT (TB PET/CT) and conventional digital PET/CT. Methods This study enrolled 67 …

[HTML][HTML] Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates

B Quinn, Z Dauer, N Pandit-Taskar, H Schoder… - BMC medical …, 2016 - Springer
Background Whole body fluorine-18 fluorodeoxyglucose positron emission
tomography/computed tomography (PET/CT) is the standard of care in oncologic diagnosis …

Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations

G Brix, U Lechel, G Glatting, SI Ziegler… - Journal of Nuclear …, 2005 - Soc Nuclear Med
We investigated radiation exposure of patients undergoing whole-body 18F-FDG PET/CT
examinations at 4 hospitals equipped with different tomographs. Methods: Patient doses …

Quantitation of cancer treatment response by 18F-FDG PET/CT: multicenter assessment of measurement variability

H Jacene, B Luber, H Wang, MH Huynh… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The aim of this study was to assess the interobserver variability of quantitative 18F-FDG
PET/CT parameters used in assessments of treatment response across multiple sites and …

Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT

Y Hu, G Liu, H Yu, J Gu, H Shi - European Journal of Nuclear Medicine …, 2022 - Springer
Purpose To comparatively evaluate the diagnostic performances of total-body 18F-
fluorodeoxyglucose positron-emission tomography/computed tomography (18F-FDG …

One-stop [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study

G Liu, W Mao, H Yu, Y Hu, J Gu, H Shi - European Journal of Nuclear …, 2023 - Springer
Purpose Positron emission tomography/computed tomography (PET/CT) based on fibroblast
activation protein inhibitors (FAPI) has shown complementary values to 2-[18F]-fluoro-2 …